Subcutaneous Emphysema: Clinical Trials

2 trials for Subcutaneous Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Active not recruiting 1, Completed 1

Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
YOLT-202 - Alpha-1 Antitrypsin Deficiency (AATD)
Early Phase 1Active not recruitingRenJi Hospital182025-06-182025-09-26
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
rAAV2-CB-hAAT Gene Vector - Alpha 1-Antitrypsin Deficiency
Early Phase 1CompletedUniversity of Massachusetts, Worcester122004-03-012020-04-10

Narrower conditions

alpha 1-Antitrypsin Deficiency (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Emphysema (2)  ·  Genetic Diseases, Inborn (2)  ·  Liver Diseases (2)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)

Sponsors

RenJi Hospital (1)  ·  University of Massachusetts, Worcester (1)

Countries

China (1)  ·  United States (1)

Top investigators

Terence R. Flotte, MD (1)

Results publications

PMID 34256305

NIH funding

R01HL069877 (1)